<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: New approach to cancer vaccines proves successful in early studies</title>
	<atom:link href="http://floridabiotechnews.com/biotech/new-approach-to-cancer-vaccines-proves-successful-in-early-studies/7065/feed/" rel="self" type="application/rss+xml" />
	<link>http://floridabiotechnews.com/biotech/new-approach-to-cancer-vaccines-proves-successful-in-early-studies/7065/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=new-approach-to-cancer-vaccines-proves-successful-in-early-studies</link>
	<description>Biotechnology news and developments from Florida. Directory of Florida biotech companies.</description>
	<lastBuildDate>Tue, 30 Apr 2013 12:02:05 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.3</generator>
	<item>
		<title>By: Bruce Walck</title>
		<link>http://floridabiotechnews.com/biotech/new-approach-to-cancer-vaccines-proves-successful-in-early-studies/7065/comment-page-1/#comment-12263</link>
		<dc:creator>Bruce Walck</dc:creator>
		<pubDate>Fri, 01 Jul 2011 07:23:54 +0000</pubDate>
		<guid isPermaLink="false">http://floridabiotechnews.com/?p=7065#comment-12263</guid>
		<description>http://seekingalpha.com/article/277382-ziopharm-small-molecules-meet-next-generation-synthetic-biology


We are entering a new era in drug development. Please see article above. ZIOPHARM-INTREXON partnership may usher in low cost DNA oncology platform that alters development model. Vaccine-like effect noted in small human melanoma trial. I have followed(and owned shares in company) for several years and never envisioned that this small molecule researcher would morph into a scalable maker of transgenes. Very interesting story that hopefully moves the needle in cancer research.</description>
		<content:encoded><![CDATA[<p><a href="http://seekingalpha.com/article/277382-ziopharm-small-molecules-meet-next-generation-synthetic-biology" rel="nofollow">http://seekingalpha.com/article/277382-ziopharm-small-molecules-meet-next-generation-synthetic-biology</a></p>
<p>We are entering a new era in drug development. Please see article above. ZIOPHARM-INTREXON partnership may usher in low cost DNA oncology platform that alters development model. Vaccine-like effect noted in small human melanoma trial. I have followed(and owned shares in company) for several years and never envisioned that this small molecule researcher would morph into a scalable maker of transgenes. Very interesting story that hopefully moves the needle in cancer research.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
